fda statement bpc-157 not approved fda.gov Ban Lifted by Advisory Committee | Eric Topol, MD posted on the topic Peptides like BPC-157 and TB-500

scroll to zoom

The peptide reduces tumor necrosis factor-alpha (TNF-) and interleukin-6 (IL-6) expression in gastric tissue exposed to indomethacin, a known ulcerogen

demonstrated in 2001 that AOD-9604 stimulates lipolysis in adipose tissue without activating the growth hormone receptor, a finding that separated its fat-metabolizing action from GH-related proliferative risks [1]

the injections are prescribed and given intramuscularly

Injections provide higher concentrations directly to damaged tissues, while oral capsules support overall recovery

It is meant to augment and not replace consultation with a licensed health care provider